Freedman MS, Pozzilli C, Havrdova EK, Lemle A, et al. Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results from Randomized Phase 2b Core and Extension Studies. Neurology 2022 Jun 6. pii: WNL.0000000000200606.
PMID: 35667837